What Is ZBH Fair Value?
Zimmer Biomet (ZBH) fair value estimate using multiple valuation models, updated daily.
As of August 29, 2026, Zimmer Biomet (ZBH) has a composite fair value estimate of $109.63 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $100.91, suggesting the stock is fair value by 8.6%.
Data as of August 29, 2026 (today)
Composite Fair Value
Fair Value4 of 4 models$109.63
vs. current price of $100.91(+8.6%)
How Is ZBH Fair Value Calculated?
Four independent models estimate what ZBH is worth. Each uses different inputs and assumptions. The composite blends them by weight.
ZBH Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$137.93
+36.7%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$22.08
-78.1%Overvalued
Inputs used
ZBH Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$112.77
+11.8%Fair Value
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$85.34
-15.4%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $100.91 is 36.7% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.15B | $1.08B |
| Year 2 | $1.21B | $1.07B |
| Year 3 | $1.27B | $1.06B |
| Year 4 | $1.33B | $1.05B |
| Year 5 | $1.40B | $1.04B |
| Year 6 | $1.48B | $1.03B |
| Year 7 | $1.55B | $1.02B |
| Year 8 | $1.63B | $1.01B |
| Year 9 | $1.72B | $1.00B |
| Year 10 | $1.80B | $991.8M |
| Terminal Value | $50.45B | $27.73B |
What Are ZBH's Key Financial Metrics?
Earnings & Growth
Current Price
$100.91
EPS (TTM)
$4.18
Forward P/E
11.1
Profit Margin
9.5%
Cash & Balance Sheet
Free Cash Flow
1.1B
EBITDA
2.6B
Book Value
$66.23
Total Debt
7.6B
What Do Analysts Say About ZBH?
Low
$93.00
Average
$107.57
High
$130.00
Upside
+6.6%
ZBH Fair Value FAQ
What is the fair value of ZBH?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), ZBH's estimated fair value is $109.63. The stock is currently trading at $100.91, which makes it fair value by our analysis.
How is ZBH's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is ZBH overvalued or undervalued?
Based on our analysis, ZBH is fair value. The current price of $100.91 is 8.6% below our estimated fair value of $109.63.
What do Wall Street analysts say about ZBH?
21 analysts cover Zimmer Biomet with a consensus rating of "." The average price target is $107.57, ranging from $93.00 to $130.00. This implies 6.6% upside from the current price.